Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1242 (LINC01242) is a human gene encoding a long, non-coding RNA transcript that does not overlap any protein-coding genes[1][3][5]. LINC01242 is part of a class of regulatory RNA molecules known as lncRNAs, which have been implicated in diverse cellular functions—including regulation of neighboring gene expression, modulation of transcriptional programs, and epigenetic control[5][7]. Although most lncRNAs remain poorly understood, high-throughput genomics suggests potential roles in cell cycle regulation and cancer[2][7]. To date, LINC01242 has not been validated as a direct therapeutic target, nor does it have any approved drugs acting upon it. Its primary relevance is in research and possibly as a biomarker in gene expression profiling for diseases like cancer[2].
Not applicable; no drugs directly target this molecule. RNA molecules like lincRNAs are sometimes indirectly modulated by epigenetic drugs or transcriptional therapies, but no specifics for LINC01242.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1242 (LINC01242).